This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, R. D. Articles by Fidler, I. J. Search for Related Content PubMed PubMed Citation Articles by Zhang, R. D. Articles by Fidler, I. J.

American Journal of Pathology, Vol 141, 1115-1124, Copyright © 1992 by American Society for Investigative Pathology

REGULAR ARTICLES

Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice

RD Zhang, JE Price, T Fujimaki, CD Bucana and IJ Fidler
Department of Cell Biology, University of Texas, M. D. Anderson Cancer Center, Houston 77030.

This study clarified whether and when the blood-brain barrier in experimental brain metastases is impaired by using hydrosoluble sodium fluorescein (MW 376) as a blood-brain barrier function indicator. Cells from eight human tumor lines (four melanomas, two breast carcinomas, one colon carcinoma, and one renal carcinoma) were inoculated into the internal carotid artery of nude mice. Brain metastases at different stages of development were sampled and the permeability of the blood- brain barrier around the metastases determined. Histologic examination showed two patterns of tumor growth. In the first, tumor cells formed isolated, well-defined nodules in the parenchyma of the brain. In lesions smaller than 0.2 mm2, the blood-brain barrier was intact. In the second, small diffuse nests of tumor cells were distributed throughout the brain parenchyma. The blood-brain barrier was intact until the small tumor cell colonies coalesced to form large tumor masses. These results suggest that the permeability of the blood-brain barrier varies among different experimental brain metastases and that its function is related to the growth pattern and size of the lesions.

This article has been cited by other articles:

				E. R. Gerstner and R. L. Fine Increased Permeability of the Blood-Brain Barrier to Chemotherapy in Metastatic Brain Tumors: Establishing a Treatment Paradigm J. Clin. Oncol., June 1, 2007; 25(16): 2306 - 2312. [Abstract] [Full Text] [PDF]

				Y. Zhang, Y.-f. Zhang, J. Bryant, A. Charles, R. J. Boado, and W. M. Pardridge Intravenous RNA Interference Gene Therapy Targeting the Human Epidermal Growth Factor Receptor Prolongs Survival in Intracranial Brain Cancer Clin. Cancer Res., June 1, 2004; 10(11): 3667 - 3677. [Abstract] [Full Text] [PDF]

				D. R. Siwak, A. M. Tari, and G. Lopez-Berestein The Potential of Drug-carrying Immunoliposomes as Anticancer Agents : Commentary re: J. W. Park et al., Anti-HER2 Immunoliposomes: Enhanced Efficacy due to Targeted Delivery. Clin. Cancer Res., 8: 1172-1181, 2002. Clin. Cancer Res., April 1, 2002; 8(4): 955 - 956. [Full Text] [PDF]

				A. Kurihara and W. M. Pardridge Imaging Brain Tumors by Targeting Peptide Radiopharmaceuticals through the Blood-Brain Barrier Cancer Res., December 1, 1999; 59(24): 6159 - 6163. [Abstract] [Full Text] [PDF]

				D. C. Drummond, O. Meyer, K. Hong, D. B. Kirpotin, and D. Papahadjopoulos Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors Pharmacol. Rev., December 1, 1999; 51(4): 691 - 744. [Abstract] [Full Text] [PDF]